Cargando…

Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema

PURPOSE: To examine the comorbidity profile and update estimates of health care resource utilization for commercially insured, working-age adults with diabetic macular edema (DME) relative to a matched comparison group of diabetic adults without DME. Additional comparisons were made in the subgroup...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiss, Szilárd, Chandwani, Hitesh S, Cole, Ashley L, Patel, Vaishali D, Lunacsek, Orsolya E, Dugel, Pravin U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153291/
https://www.ncbi.nlm.nih.gov/pubmed/27994438
http://dx.doi.org/10.2147/OPTH.S114006
_version_ 1782474667894767616
author Kiss, Szilárd
Chandwani, Hitesh S
Cole, Ashley L
Patel, Vaishali D
Lunacsek, Orsolya E
Dugel, Pravin U
author_facet Kiss, Szilárd
Chandwani, Hitesh S
Cole, Ashley L
Patel, Vaishali D
Lunacsek, Orsolya E
Dugel, Pravin U
author_sort Kiss, Szilárd
collection PubMed
description PURPOSE: To examine the comorbidity profile and update estimates of health care resource utilization for commercially insured, working-age adults with diabetic macular edema (DME) relative to a matched comparison group of diabetic adults without DME. Additional comparisons were made in the subgroup of pseudophakic patients. PATIENTS AND METHODS: A retrospective matched-cohort study of commercially insured diabetic adults aged 18–63 years was conducted using medical and outpatient pharmacy claims (July 1, 2008–June 30, 2013). Outcomes included diabetes-related and ocular comorbidities and health care resource utilization (any health care visit days, outpatient visit days, inpatient visit days, emergency room visits, eye care-related visit days, unique medications) in the 12-month post-index period. RESULTS: All diabetes-related and ocular comorbidities were significantly more prevalent in DME cases versus non-DME controls (P<0.05). A significantly greater proportion of DME cases utilized eye care-related visits compared with non-DME controls (P<0.001). DME cases had almost twice the mean number of total health care visit days compared to non-DME controls (28.6 vs 16.9 days, P<0.001), with a minority of visit days being eye care-related (mean 5.1 vs 1.5 days, P<0.001). Similar trends were observed in pseudophakic cohorts. CONCLUSION: This working-age DME population experienced a mean of 29 health care visit days per year. Eye care-related visit days were a minority of the overall visit burden (mean 5 days) emphasizing the trade-offs DME patients face between managing DME and their overall diabetic disease. Insights into the complex comorbidity profile and health care needs of diabetic patients with DME will better inform treatment decisions and help optimize disease management.
format Online
Article
Text
id pubmed-5153291
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-51532912016-12-19 Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema Kiss, Szilárd Chandwani, Hitesh S Cole, Ashley L Patel, Vaishali D Lunacsek, Orsolya E Dugel, Pravin U Clin Ophthalmol Original Research PURPOSE: To examine the comorbidity profile and update estimates of health care resource utilization for commercially insured, working-age adults with diabetic macular edema (DME) relative to a matched comparison group of diabetic adults without DME. Additional comparisons were made in the subgroup of pseudophakic patients. PATIENTS AND METHODS: A retrospective matched-cohort study of commercially insured diabetic adults aged 18–63 years was conducted using medical and outpatient pharmacy claims (July 1, 2008–June 30, 2013). Outcomes included diabetes-related and ocular comorbidities and health care resource utilization (any health care visit days, outpatient visit days, inpatient visit days, emergency room visits, eye care-related visit days, unique medications) in the 12-month post-index period. RESULTS: All diabetes-related and ocular comorbidities were significantly more prevalent in DME cases versus non-DME controls (P<0.05). A significantly greater proportion of DME cases utilized eye care-related visits compared with non-DME controls (P<0.001). DME cases had almost twice the mean number of total health care visit days compared to non-DME controls (28.6 vs 16.9 days, P<0.001), with a minority of visit days being eye care-related (mean 5.1 vs 1.5 days, P<0.001). Similar trends were observed in pseudophakic cohorts. CONCLUSION: This working-age DME population experienced a mean of 29 health care visit days per year. Eye care-related visit days were a minority of the overall visit burden (mean 5 days) emphasizing the trade-offs DME patients face between managing DME and their overall diabetic disease. Insights into the complex comorbidity profile and health care needs of diabetic patients with DME will better inform treatment decisions and help optimize disease management. Dove Medical Press 2016-12-07 /pmc/articles/PMC5153291/ /pubmed/27994438 http://dx.doi.org/10.2147/OPTH.S114006 Text en © 2016 Kiss et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Kiss, Szilárd
Chandwani, Hitesh S
Cole, Ashley L
Patel, Vaishali D
Lunacsek, Orsolya E
Dugel, Pravin U
Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema
title Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema
title_full Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema
title_fullStr Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema
title_full_unstemmed Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema
title_short Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema
title_sort comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153291/
https://www.ncbi.nlm.nih.gov/pubmed/27994438
http://dx.doi.org/10.2147/OPTH.S114006
work_keys_str_mv AT kissszilard comorbidityandhealthcarevisitburdeninworkingagecommerciallyinsuredpatientswithdiabeticmacularedema
AT chandwanihiteshs comorbidityandhealthcarevisitburdeninworkingagecommerciallyinsuredpatientswithdiabeticmacularedema
AT coleashleyl comorbidityandhealthcarevisitburdeninworkingagecommerciallyinsuredpatientswithdiabeticmacularedema
AT patelvaishalid comorbidityandhealthcarevisitburdeninworkingagecommerciallyinsuredpatientswithdiabeticmacularedema
AT lunacsekorsolyae comorbidityandhealthcarevisitburdeninworkingagecommerciallyinsuredpatientswithdiabeticmacularedema
AT dugelpravinu comorbidityandhealthcarevisitburdeninworkingagecommerciallyinsuredpatientswithdiabeticmacularedema